Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows
May 25, 2018 11:39 am | Ana Pena
Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed chemotherapy, a study suggests. The study, “DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine,” was published in The Journal of Clinical Investigation. “There is […]
The post Dacogen Shows Promise in Triple-negative Breast Cancer Animal Models, Study Shows appeared first on Breast Cancer News. |
|
|
Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials
May 23, 2018 02:13 pm | Marta Figueiredo
Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according to a press release. Although breast cancer detection using mammography has saved the lives of many women, it still fails to detect 10-25 percent of tumors […]
The post Imagion’s Breast Cancer Detection Method Using Magnetic Nanoparticles Moving into Clinical Trials appeared first on Breast Cancer News. |
|
|
Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Finds
May 21, 2018 12:20 pm | Marta Figueiredo
A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The results will be presented at the 2018 American Society of Clinical Oncology (ASCO) meeting beginning June 4, in Chicago, in a presentation titled “PERSEPHONE: 6 versus 12 […]
The post Herceptin Treatment Time Could be Halved for Breast Cancer, Phase 3 Trial Findsappeared first on Breast Cancer News. |
|
|
|
Dacogen (decitabine), a medicine used for treating a group of blood cell disorders, may be a potential new treatment for women with triple-negative breast cancer, including those who failed chemotherapy, a study suggests. The study, “DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine,” was published in The Journal of Clinical Investigation. “There is […]
Imagion Biosystems‘ experimental breast cancer detection method — involving magnetic nanoparticles that stick to breast cancer cells — will be tested in a clinical trial later this year, according to a press release. Although breast cancer detection using mammography has saved the lives of many women, it still fails to detect 10-25 percent of tumors […]
A shorter Herceptin (trastuzumab) treatment — six months instead of the standard 12 months — is equally effective and carries fewer heart-related adverse effects, a Phase 3 clinical trial found. The results will be presented at the 2018 American Society of Clinical Oncology (ASCO) meeting beginning June 4, in Chicago, in a presentation titled “PERSEPHONE: 6 versus 12 […]
Comments